About this Research Topic
Although SARS-CoV-2 infections primarily infect the lungs in humans, they affect the immune response in the entire host. It changes the composition of the human microbiome both with the effect of the COVID-19 infection itself and with the effect of the drugs used in the treatment process. With the combination of next-generation sequencing techniques, bioinformatic analyses, and immune response detection studies, it has started to be understood how different human microbiome compositions regulate or change the immune system, and how this differentiation interacts in different infections such as COVID-19 has attracted interest. The effects of microbiomes other than the gut microbiome and how the virome, mycobiome or parasitome compositions change and interact, apart from the bacteriome composition, are of interest, A better understanding of the mechanisms governing the constituents of the human microbiome, their shifts during health and COVID-19 is needed.
The aim of this Research Topic is to provide an up-to-date summary to explore relationships between the human microbiome and COVID-19. This research topic will also aim to reveal the different human microbiome composition altered in SARS-COV-2 infections and will lead to recent data that will reveal that the human microbiome is not limited to the gut microbiome or bacteria alone.
The following types of papers will be accepted: original research, clinical trials, review, systematic review, brief research report, case report, mini review, perspective, general commentary, and opinion.
The following themes are welcome:
• Studies connecting the human microbiome and COVID-19;
• Studies analyzing the microbiome composition and functional variation among COVID-19 patients.
• Unravelling the role of the human microbiome on COVID-19 etiology, physiology, and its response to medications and clinical procedures.
• Studies connecting the human microbiome-immune homeostasis and regulation of the immune response on COVID-19
• Studies analyzing the human microbiome interventions including diet, supplements, clinical trials, or therapies on SARS-COV-2 infections
The aim of this Research Topic is to provide an up-to-date summary to explore relationships between the human microbiome and COVID-19. This research topic will also aim to reveal the different human microbiome composition altered in SARS-COV-2 infections and will lead to recent data that will reveal that the human microbiome is not limited to the gut microbiome or bacteria alone.
The following types of papers will be accepted: original research, clinical trials, review, systematic review, brief research report, case report, mini review, perspective, general commentary, and opinion.
The following themes are welcome:
• Studies connecting the human microbiome and COVID-19;
• Studies analyzing the microbiome composition and functional variation among COVID-19 patients.
• Unravelling the role of the human microbiome on COVID-19 etiology, physiology, and its response to medications and clinical procedures.
• Studies connecting the human microbiome-immune homeostasis and regulation of the immune response on COVID-19
• Studies analyzing the human microbiome interventions including diet, supplements, clinical trials, or therapies on SARS-COV-2 infections
Keywords: Human microbiota, COVID-19, SARS-COV-2, immune response, pathogenesis, pathophysiology, mechanisms
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
